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Abstract
Background: The Arthritis Impact Measurement Scales 2 (AIMS2) has not been translated and validated for Persian-speaking
patients with osteoarthritis of the knee. This was to provide a validated instrument to measure functional disability and health-
related quality of life in patients with osteoarthritis of the knee in Iran. The aim of this study was to culturally adapt and validate
the AIMS2 for Persian-speaking patients with osteoarthritis of the knee in Iran.
Methods: A consecutive sample of patients with knee osteoarthritis were asked to complete the AIMS2, the Short Form Health
Survey (SF-36) and four visual analog scales for pain, joint stiffness, patient's and physician's global assessment. Internal
consistency and convergent validity were applied to examine psychometric properties of the AIMS2. In addition, 30 randomly
selected patients were asked to complete the questionnaire two days later for the second time for test-retest reliability. Finally
factor structure of the Persian AIMS2 was performed using the principal component factor analysis.
Results: In all 230 patients were entered into the study. The mean (SD) age of the participants was 56.9 (8.7) years and the
mean (SD) duration of disease was 7.2 (3.5) years. Cronbach's alpha coefficient and intraclass correlation coefficient (ICC) for
the Persian AIMS2 scales ranged from 0.74 to 0.92 and 0.85 to 0.96, respectively. The correlation between most of the Persian
AIMS2 scales and the physical and mental summary scores of the SF-36 and the visual analogue scales for pain, joint stiffness,
patient's and physician's global assessment were statistically significant indicating a good convergent validity (p < 0.05). The
results obtained from factor analysis indicated three latent factors that jointly accounted for 67.5% of the total variance.
Conclusion: The results showed that the Persian AIMS2 had reasonably good internal consistency, test-retest reliability, and
convergent validity in patients with osteoarthritis of the knee. It is simple and easy to use and now can be applied in the future
studies in Iran. However, its sensitivity to change needs still to be studied.
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Background
Osteoarthritis (OA) is a major medical, social, and eco-
nomic problem in both developed and developing coun-
tries [1-3]. It often affects a variety of physical and
psychosocial health domains, from fairly basic self-care
activities to advance and complex social, work, and leisure
activities and eventually has a profound impact on health
related quality of life (HRQOL) [2,4,5]. Osteoarthritis of
the knee is the most prevalent degenerative joint disease
and a major cause of disability, particularly in the aging
population [6,7]. Cross-sectional and prospective studies
found that HRQOL is negatively affected in patients with
OA of the knee [2,3,8,9]. The aim of contemporary treat-
ment in most of the rheumatoid and orthopaedic condi-
tions, including OA of the knee, is often to improve the
functional ability and quality of life of the patient; hence
health status should be considered as an important out-
come in clinical trials investigating OA of the knee
[10,11].
The Arthritis Impact Measurement Scales 2 (AIMS2) is a
shorter version of the AIMS and has been developed for
the purpose of assessing the impact of arthritis on
patient's quality of life [12,13]. This short version has
been shown to be more comprehensive, and acceptable to
patients than AIMS while it takes a shorter time to be com-
pleted [13]. Several studies of patients with rheumatoid
arthritis proved that it is as reliable and valid as the longer
version [13-15]. This questionnaire has been translated
into many different languages [14-20]. The psychometric
properties of the Italian [17], Chinese [18], Turkish [19],
and German [20] versions of the AIMS2 have been evalu-
ated in patients with OA of the knee and/or hip.
There is an increasing need for internationally standard-
ized instruments to measure health status in patients with
OA of the knee in a manner that allows comparison across
cultures and countries [21,22]. Osteoarthritis of the knee
is the most common disease among adults in Iran, with
reported 7-days period prevalence of symptomatic OA as
high as 15.3% in urban [23] and 19.3% in rural areas [24].
Given the population of Iran (over 70 million) and high
prevalence of OA of the knee in the country, the AIMS2,
as an internationally recognized instrument for patients
with osteoarthritis, was not yet validated in Iran. This
study aimed to translate and culturally adapt the AIMS2
for use with Persian-speaking patients with OA of the knee
in Iran, and to investigate its psychometric properties.
Methods
Translation and cultural adaptation
Forward-backward procedure was applied to translate the
English version of the AIMS2 into Persian (the Iranian
language). Two independent professional translators pro-
duced two forward translations. Both translators were
instructed to aim for conceptual rather than literal trans-
lation. Together with one of the authors, the translators
compared their translations and produced a single provi-
sional version of the questionnaire. Totally blind to the
original version, two other professional translators trans-
lated the provisional Persian questionnaire back into the
English language. The two translators were not aware of
the questionnaire. Finally, an expert committee consisted
of the translators, the researchers, two rheumatologists,
one orthopedics surgeon and one specialist in psychomet-
ric reviewed all the translation and cultural adaptation
processes. They also evaluated the final English backward
version with the original questionnaire. Consensus in
terms of semantic, idiomatic, experiential, and conceptual
equivalence was reached and a pre-final version of the
questionnaire (the Persian AIMS2) was provided. In gen-
eral the original scales were remained unchanged except
some minor modifications in items 7, 9 and 33. In items
7 and 9, 'walking several blocks' and 'walking one block'
have been changed to 'walking several alleys' and 'walking
one alley', respectively to refer to a similar distance in Per-
sian language. In item 33, 'church' was changed to 'reli-
gious meetings' to imply comparable meaning.
The AIMS2
The AIMS2 consists of 78 items and the first 57 items are
broken to 12 scales and measuring: mobility level (5
items), walking and bending (5 items), hand and finger
function (5 items), arm function (5 items), self care (4
items), household tasks (4 items), social activities (5
items), support from family and friends (4 items), arthri-
tis pain (5 items), work (5 items), level of tension (5
items) and mood (5 items). Scores on each scale range
from 0 to 10 with lower scores indicating better quality of
life [12]. Usually these scales refer to the shorter version of
AIMS2 that was used in this study and should not be con-
fused with the 'Short Form' version of the AIMS2 known
as AIMS2-SF.
However, the remaining 21 items of the questionnaire are
related to satisfaction with each area of health (1 item),
arthritis impact on each area of health (1 item), three
areas most like to see improvement (1 item), current and
future health (5 items), overall arthritis impact (3), medi-
cation (1 item), co-morbidity (3 item), socio-economic
status (6 items).
Additional measures
The SF-36
The SF-36 is a general health questionnaire that consists of
36 items, summarized into eight subscales. The eight sub-
scales are summarized into physical component scores
(PCS) and mental component score (MCS). The PCS and
MCS provide greater precision, and reduce the number of
statistical comparisons needed [25]. The psychometricBMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
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properties of the Iranian version of SF-36 are well docu-
mented [26].
Clinical Measures
The patient's perception of pain, joint stiffness, and global
severity assessment level was measured on a 100 mm vis-
ual analogue scale (VAS) ranging from zero (representing
'no pain', 'no stiffness', 'no problem') to 100 (representing
'maximum imaginable pain', 'extreme stiffness' or '
extremely severe)'. Similarly, the physician's global assess-
ment of disease severity was recorded using a 100 mm
VAS anchored by word descriptors at each end (0 =
'asymptomatic', 100 = 'extremely severe').
Patients
A consecutive sample of 230 patients with symptomatic
OA of the knee for at least one year duration who were
referred to 6 rheumatology and physical therapy clinics in
Tehran, Iran, were entered into the study over a period of
11 months. All patients fulfilled clinical and radiological
criteria for OA of the knee according to the American Col-
lege of Rheumatology (ACR) [27]. A rheumatologist clas-
sified severity of radiological severity of OA of the knee
according to the Kellgren-Lawrence standard criteria. This
is a four-grade scale with higher grade indicating more
severity [28]. In order to carry out the test-retest reliability
a total of 30 patients, randomly selected from the original
group, completed the Persian AIMS2 again 2 days later, in
the same manner as the first one. Patients with recent
lower extremity fractures and operation, inflammatory
arthritis (e.g., rheumatoid arthritis), systematic inflamma-
tory disease, and relevant comorbidities such as cancer,
infectious disease, heart attack or clinically recognizable
cognitive impairment were excluded from the study.
Statistical analysis
Distribution of data
Kolmogorov-Smirnov test was used to assess distribution
of the Persian AIMS2, MCS, PCS, and the VAS scores. The
interval measurements were normally distributed, and
therefore several parametric tests were employed to ana-
lyze data. The critical values for significance were set at p
< 0.05.
Reliability
Reliability of measurement refers to the extent, to which
the measured variance in a score reflects the true score,
rather than random error; that is, the extent to which
measures give consistent or accurate results [29]. Two
common forms of reliability are internal consistency
method and test-retest reliability. The internal consistency
of a scale relates to its homogeneity. The higher the coef-
ficient value, the higher the reliability and the lower the
standard error of measurement. The internal consistency
was assessed with the Cronbach's alpha coefficient that
ranges from zero to 1 and values equal or greater than
0.70 indicate adequate internal consistency for a scale
[29]. Test-retest reliability measures stability over time, by
administering the same test to the same subjects at two
points in time [29]. In this study, 30 randomly selected
patients completed the Persian AIMS2 twice with a time
interval of 2 days. Test-retest reliability was examined
using Intraclass Correlation Coefficient (ICC). Values of
ICC vary from zero (totally unreliable) to 1 (perfectly reli-
able) and values above 0.80 were considered as evidence
of excellent reliability [29].
Convergent validity
Convergent validity examines the extent to which a partic-
ular measure relates to other measures that is believed to
be assessing the same construct [30]. In the absence of a
true 'gold standard" against which to assess criterion
validity of the Persian AIMS2, we compared this question-
naire with commonly used external measures likely to
reflect the impact of knee OA. Thus, correlation between
the Persian AIMS2 and the physical and mental compo-
nent summary scores of the SF-36, and clinical measures
(i.e. patient's pain, joint stiffness, global assessment, and
physician's global assessment of disease severity) was
measured. It was expected that physical constructs of the
AIMS2 would be correlated with physical, and mental
constructs of the AIMS2 would be correlated with mental
components of the SF-36. The Pearson's correlation coef-
ficient was used to test convergent validity of the Persian
AIMS2. Correlation values of 0.40 or above were consid-
ered satisfactory (r ≥ 0.81–1.0 as excellent, 0.61–0.80 very
good, 0.41–0.60 good, 0.21–0.40 fair, and 0–0.20 poor)
[29,31].
Factor analysis
Finally factor analysis was applied to determine the
dimensionality of the items of a questionnaire that is, to
determine whether they formed only one overall dimen-
sion or more than one [31]. Factor structure of the Persian
AIMS2 was performed using the principal component fac-
tor analysis with varimax rotation.
Ethics
The Ethics Committee of the Tehran University of Medical
Sciences approved the study. All patients gave informed
consent.
Results
Table 1 summarizes the demographic and clinical charac-
teristics of the study population as well as descriptive sta-
tistics of the distribution for the scales. The mean (SD) age
of the participants was 56.9 (8.7) years ranging from 36 to
76. Sixty-eight percents of the respondents were female.
The mean duration of disease was 7.2 ± 3.5 years. At the
time of enrollment, 80% of the subjects were workingBMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
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Table 1: Demographic and clinical characteristics of the study population and distribution of scores for each questionnaire (n = 230)
Mean SD
Age Years 56.9 8.7
Disease duration Years 7.2 3.5
SF-36 (0–100)
PCS 33.4 8.2
MCS 44.2 9.9
VAS (0–100)
Pain 55.2 22.1
Stiffness 48.4 16.5
Patient's assessment 58.6 12.9
Physician's assessment 49.7 15.4
Kellgren-Lawrence score (%) 2.7 0.79
Grade I 28 8.5
Grade II 163 49.4
Grade III 117 35.5
Grade IV 22 6.6
AIMS2 Scales (0–10)
Mobility level 3.02 2.1
Walking and bending 6.0 2.34
Hand and finger function 1.05 1.1
Arm function 1.41 1.5
Self-care 1.2 1.4
House holding tasks 1.98 2.1
Social activities tasks 4.93 2.4
Support from family and friends 2.1 1.5
Arthritis pain 5.89 2.5
Work 3.98 1.8
Level of tension 5.1 1.9
Mood 3.4 1.4
AIMS2: Arthritis Measurement Scales 2; SF-36: Short Form Health Survey; PCS: Physical Component Summary; MCS: Mental Component Summary, VAS: Visual 
Analogue Scale.BMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
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(considering household work also as work for women),
12% were retired, and 8% had stopped working because
of their knee pain. All subjects were affected by OA of the
knee with a radiological severity mostly of the second and
third degrees on Kellgren-Lawrence's scale (49.2% and
35.5%, respectively). The mean time to complete the Per-
sian AIMS2 was approximately 23 minutes. In general
most participants found the Persian AIMS2 easy to com-
plete and relevant to their current lower extremity prob-
lem. Most patients (95%) completed the questionnaire
without any missing data.
Reliability
Table 2 shows the main results of scale reliability analyses.
Cronbach's coefficient ranged from 0.74 for arm function
to 0.92 for work. Intraclass correlation coefficient value
for the Persian AIMS2 ranged from 0.85 for social activi-
ties to 0.96 for mobility level, which indicates excellent
test-retest reliability for the AIMS2 scales.
Convergent validity
Table 3 summarizes the statistical analyses of correlation
between the Persian AIMS2 and the external measures,
using Pearson's correlation coefficient. Good significant
correlations were found between the PCS and most of the
Persian AIMS2 scales, except for support from family and
friends, level of tension and mood scales as expected. The
PCS had the highest correlation with mobility level, walk-
ing and bending and arthritis pain and lowest correlation
with support from family and friends lending support to
our hypothesis. The MCS were significantly correlated
with most of the Persian AIMS2 scales. The highest corre-
lation was observed between the MCS and tension and
mood scale scores as predicted.
Moderate to high correlations were observed between
mobility level, walking and bending, work, and level of
tension scales and VAS measures for pain, joint stiffness,
patient's and physician's global assessment. The highest
correlations were found between arthritis pain scale and
the VAS for pain and joint stiffness. The scores for hand
and finger function, arm function, household tasks and
mood scales were moderately correlated with most meas-
ures. The social activities and support from family and
friends scales were not significantly correlated with clini-
cal measures.
Factor analysis
A factor analysis with varimax rotation was performed
and 3 latent factors extracted with eigenvalues greater than
1 that jointly accounted for 67.5% of the total variance.
The lower-limb (mobility level and walking and bending)
and upper-limb (hand and finger function, arm function)
functioning scales together with the self care, household
Table 2: Internal consistency and test-retest reliability of the Persian AIMS2
Internal consistency (Cronbach's alpha) Test-retest reliability (ICC)
Mobility level 0.83 0.94
Walking and bending 0.81 0.92
Hand and finger function 0.84 0.90
Arm function 0.79 0.89
Self-care 0.89 0.93
Household tasks 0.88 0.91
Social activities 0.84 0.92
Support from family and friends 0.78 0.85
Arthritis pain 0.83 0.90
Work 0.81 0.94
Level of tension 0.84 0.89
Mood 0.79 0.94
AIMS2: Arthritis Measurement Scales 2; ICC: Intraclass Correlation Coefficient.BMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
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tasks, arthritis pain and work scales formed the first factor,
which explained 47% of the total variance measured. The
psychological scales (level of tension and mood) were
loaded on the second factor, which explained 11.1% of
the variance. The third factor (9.4% of the variance) was
determined by the social dimension, consisting of the
social activities and support from family and friends scales
(Table 4).
Discussion
The results of present study have shown satisfactory inter-
nal consistency, test-retest reliability, and convergent
validity for the Persian AIMS2 in patients with osteoarthri-
tis of the knee. The questionnaire covers most important
areas of health status that are influenced by knee OA. With
the growing number of multinational and multi-center
studies, the need to culturally adapt health status meas-
ures for use in other than the original source language has
grown rapidly [32]. The presence of an internationally val-
idated instrument for knee OA would allow direct com-
parison across countries and centers.
Our findings suggested satisfactory internal consistency
for the Persian AIMS2. The Cronbach's alpha of the Per-
sian AIMS2 ranged from 0.74 to 0.91 that is comparable
to results previously reported for Italian (0.72–0.92),
Turkish (0.72–0.90), and German (0.73–0.88) versions of
the AIMS2 [17,19,20]. In addition, the Persian AIMS2
showed excellent test-retest reliability, with ICC ranging
from 0.83 to 0.96. Similar ICC values have been reported
in Italian (0.70–90), Turkish (0.75–0.98), and German
studies (0.87–0.95) [17,19,20].
The Persian AIMS2 showed significant good convergent
validity, as assessed with the physical and mental compo-
nent scores of the Persian SF-36 and clinical measures.
Satisfactory significant correlations were found between
the PCS score and most of the Persian AIMS2 scales, espe-
cially mobility level, walking and bending, and arthritis
pain. Correlation between support from family and
friends and the PCS was not significant. Fair to good cor-
relations were observed between MCS and most of the
AIMS2 scales. The highest correlation was found between
the MCS and mood, social activities and level of tension.
No significant correlation was found between the MCS
and arm function and self care. In a Chinese validation
study the World Health Organization Quality of Life ques-
tionnaire (WHOQOL-BREF) was used to test convergent
validity of the AIMS2. In their study significant correlation
were reported between physical and psychological dimen-
Table 3: The Pearson correlation coefficients of the Persian AIMS2 and the SF-36 component scores and clinical measures (n = 230)
PCS MCS Pain Stiffness Patient's assessment Physician's assessment
Mobility level -0.50** -0.18* 0.44** 0.40** 0.41* 0.45**
Walking and bending -0.67** -0.22* 0.55** 0.45** 0.50* 0.58**
Hand and finger function -0.34* -0.10* 0.13* 0.11* 0.20* 0.21*
Arm function -0.36* -0.05 0.22* 0.19* 0.31* 0.32*
Self-care -0.18* -0.10 0.30* 0.20* 0.23* 0.22*
Household tasks -0.27* -0.15* 0.18* 0.17* 0.14* 0.25*
Social activities -0.40** -0.45** 0.10 0.005 -0.01 0.17*
Support from family and friends -0.05 -0.38* 0.09 0.1 0.03 0.08
Arthritis pain -0.71** -0.29* 0.57** 0.49** 0.47** 0.50*
Work -0.58* -0.31* 0.49** 0.51** 0.55** 0.48**
Level of tension -0.29* -0.41* 0.29* 0.27* 0.21* 0.23*
Mood -0.39* -0.49** 0.27* 0.32* 0.22* 0.37**
* P < 0.05, ** P < 0.01
AIMS2: Arthritis Measurement Scales 2; SF-36: Short Form Health Survey; PCS: Physical Component Summary; MCS: Mental Component Summary, 
VAS: Visual Analogue Scale.BMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
Page 7 of 9
(page number not for citation purposes)
sions of the WHOQOL-BREF and the Chinese AIMS2
[18]. However, our findings demonstrated that the Per-
sian version of the AIMS2 is a valid instrument to measure
physical and psychosocial of HRQOL in patients with OA
of the knee.
Fair to good correlations were observed between most of
the Persian AIMS2 scales and the subjective clinical meas-
ures of pain, joint stiffness and global assessment of dis-
ease severity. All or some of these clinical measures were
used in previous studies to test convergent validity of the
Italian [17], Chinese [18], Turkish [19], and German [20],
version of the AIMS2. Stronger correlation between
mobility level and walking and bending scales and all
clinical measures were found in the present study relative
to other validation studies. Similar to German validation
[20], the correlation between social activity scale and clin-
ical measures was significant.
A three-factor solution was extracted from the factor anal-
ysis of the Persian AIMS2 that jointly accounted for the
67.5% of the total variance. In fact the result was satisfac-
tory and consistent with the theoretical basis for the orig-
inal conceptual model of the instrument. A German study
also confirmed the postulated three-factor structure for
the AIMS2 with a physical, physiological and social
dimension, explaining 48.5%, 13.9% and 6.8% of the var-
iation, respectively [20]. Similarly an Italian study indi-
cated that the factor analysis provided a three-factor
health status model explaining 63.5% of the variance
observed [17].
This study has several limitations. Perhaps the main con-
cern is that this study did not provide evidence for respon-
siveness to change or other psychometric tests (e.g.
discriminant validity). Secondly, the statistical analysis
was limited. For instance, to indicate the factor structure
of the instrument it would be interesting to carry out con-
firmatory factor analysis instead of exploratory factor
analysis. The future studies could focus on other psycho-
metric properties of the questionnaire and also on differ-
ent applications of the AIMS2 among Iranian patients.
Table 4: The factor structure of the Persian AIMS2 obtained from principal component analysis*
Factor 1 Factor 2 Factor 3
Physical Psychological Social
AIMS2 scales --
Mobility level 0.72 - -
Walking and bending 0.65 - -
Hand and finger function 0.59 - -
Arm function 0.54 - -
Self-care 0.74 - -
Household tasks 0.75 - -
Social activities - 0.60
Support from family and friends - 0.57
Arthritis pain 0.65 - -
Work 0.53 - -
Level of tension - 0.76 -
Mood - 0.67 -
Variance contributed by each factor** 47 11.1 9.4
* Factor loadings greater than 0.40 were considered satisfactory.
** Total variance explained: 67.5%.BMC Musculoskeletal Disorders 2009, 10:95 http://www.biomedcentral.com/1471-2474/10/95
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Conclusion
The present study presents initial step in evaluating psy-
chometric properties of a well-known instrument to
measure the impact of arthritis on Persian-speaking
patients with osteoarthritis of the knee in Iran. Since
health related quality of life was rarely assessed as primary
end-point in studies of osteoarthritis of the knee in Iran,
indeed the Persian AIMS2 might possibly provide both
clinicians and patients with numerous advantages as an
important outcome measure in the future studies. How-
ever, its sensitivity to change needs still to be studied.
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